Insulet Corp.
PODD
Classifica tra le azioni
#2092
Insulet Corporation develops, manufactures, and sells insulin delivery systems... Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Prezzo delle azioni
$141.47
Capitalizzazione di mercato
$9.81B
Variazione (1 giorno)
0.26%
Variazione (1 anno)
-55.60%
Paese
US
Scambia Insulet Corp. (PODD)
Categoria
Healthcare
Rapporto P/B per Insulet Corp. (PODD)
Rapporto P/B al October 2026 TTM: 6.53
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Insulet Corp., il rapporto P/B attuale (TTM) è 6.53. Alla fine del 2023, era pari a 20.66.
Storico del rapporto P/B per Insulet Corp. da 2002 a 2026
Rapporto P/B alla fine di ogni anno
| Anno | Rapporto P/B | Cambia |
|---|---|---|
| 2026 (TTM) | 6.53 | -56.78% |
| 2024 | 15.10 | -26.90% |
| 2023 | 20.66 | -51.82% |
| 2022 | 42.87 | 32.40% |
| 2021 | 32.38 | 18.10% |
| 2020 | 27.42 | -79.94% |
| 2019 | 136.68 | 520.91% |
| 2018 | 22.01 | -12.82% |
| 2017 | 25.25 | -25.35% |
| 2016 | 33.82 | -46.36% |
| 2015 | 63.05 | 106.29% |
| 2014 | 30.57 | 90.05% |
| 2013 | 16.08 | -30.14% |
| 2012 | 23.02 | 86.95% |
| 2011 | 12.31 | 32.85% |
| 2010 | 9.27 | 15.42% |
| 2009 | 8.03 | -83.90% |
| 2008 | 49.87 | 1,074.45% |
| 2007 | 4.25 | -3,051.01% |
| 2006 | -0.14 | 95.52% |
| 2005 | -0.07 | -29.23% |
| 2004 | -0.10 | -26.61% |
| 2003 | -0.14 | -44.30% |
| 2002 | -0.25 | 0.00% |
Rapporto P/B per aziende simili o concorrenti
| Azienda | Rapporto P/B | Differenza del rapporto P/B | Il paese |
|---|---|---|---|
| 3.5116 | -46.19% |
US
|
|
| 2.0146 | -69.13% |
IE
|
|
| 4.5025 | -31.01% |
US
|
|
| 2.5486 | -60.95% |
US
|
|
| - | - |
DE
|
